I
Ippei Matsumoto
Researcher at Kindai University
Publications - 206
Citations - 5318
Ippei Matsumoto is an academic researcher from Kindai University. The author has contributed to research in topics: Pancreatic cancer & Transplantation. The author has an hindex of 30, co-authored 191 publications receiving 4378 citations. Previous affiliations of Ippei Matsumoto include Kobe University & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka,Narikazu Boku,Akira Fukutomi,Yukiyasu Okamura,Masaru Konishi,Ippei Matsumoto,Yuji Kaneoka,Yasuhiro Shimizu,Shoji Nakamori,Hirohiko Sakamoto,Soichiro Morinaga,Osamu Kainuma,Koji Imai,Naohiro Sata,Shoichi Hishinuma,Hitoshi Ojima,Ryuzo Yamaguchi,Satoshi Hirano,Takeshi Sudo,Yasuo Ohashi +19 more
TL;DR: This study found that adjuvant chemotherapy with S-1 can be a new standard care for resected pancreatic cancer in Japanese patients and estimated overall and relapse-free survival using the Kaplan-Meier methods and assessed non-inferiority of S-2 to gemcitabine using the Cox proportional hazard model.
Journal ArticleDOI
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
Bernhard J. Hering,Raja Kandaswamy,Jeffrey D. Ansite,Peter Eckman,Masahiko Nakano,Toshiya Sawada,Ippei Matsumoto,Sung Hee Ihm,Hui Jian Zhang,Jamen Parkey,David W. Hunter,David E.R. Sutherland +11 more
TL;DR: The tested transplant protocol restored insulin independence and protected against hypoglycemia after single-donor, marginal-dose islet transplantation in 8 of 8 recipients, and may be related to improved islet engraftment secondary to peritransplant administration of antithymocyte globulin and etanercept.
Journal ArticleDOI
Transplantation of Cultured Islets from Two-Layer Preserved Pancreases in Type 1 Diabetes with Anti-CD3 Antibody
Bernhard J. Hering,Raja Kandaswamy,James V. Harmon,Jeffrey D. Ansite,Sue M. Clemmings,Tetsuya Sakai,Stephen Paraskevas,Peter Eckman,Junichiro Sageshima,Masahiko Nakano,Toshiya Sawada,Ippei Matsumoto,Hui J. Zhang,David E.R. Sutherland,Jeffrey A. Bluestone +14 more
TL;DR: Preliminary results suggest that a combination of maximized viable islet yield, pretransplant islet culture, and preemptive immunosuppression can result in successful single‐donor islet transplants.
Journal ArticleDOI
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi,Tomoo Kosuge,Hideki Ueno,Hiroki Yamaue,Sohei Satoi,Masayuki Sho,Goro Honda,Ippei Matsumoto,Keita Wada,Junji Furuse,Yutaka Matsuyama,Michiaki Unno +11 more
TL;DR: A randomized, controlled trial has begun to compare neoadjuvant chemotherapy using gemcitabine and S-1 with upfront surgery for patients planned resection of pancreatic cancer.
Journal ArticleDOI
Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure.
Saida Abdelli,Jeff Ansite,Raphaël Roduit,Tiziana Borsello,Ippei Matsumoto,Toshiya Sawada,Nathalie Allaman-Pillet,Hugues Henry,Jacques S. Beckmann,Bernhard J. Hering,Christophe Bonny +10 more
TL;DR: The data indicate that isolation and cytokines recruit different death pathways, and strategies might be rationally developed to avoid possible synergistic activation of these pathways in mediating islet loss during isolation and following grafting.